CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Accent Microcell Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Accent Microcell Ltd
Phone: +91 7940042367p:+91 7940042367 AHMEDABAD, 380015  India Ticker: ACCENTMICACCENTMIC
Business Summary
Accent Microcell Limited is a global manufacturer of microcrystalline cellulose. It is engaged in the manufacturing of a pharmaceutical excipients range of products. Its segments include Dahej (SEZ Unit), Pirana, and Unit III. It serves various applications, including pharmaceuticals and nutraceuticals; food, bakery and dairy; cosmeceuticals and personal care; textile, leather, paper, and boards; paints, ceramic, construction and cements; welding electrodes; rubber; filtration, plastics. Its comprehensive product portfolio is designed to meet the diverse needs of the pharmaceutical, nutraceutical, food, cosmetic and other industries. Its range includes binders, fillers, target-drug-delivery, disintegrants, lubricants, coatings, and preservatives. Its products include Micro Crystalline Cellulose, Cellulose Powder, Microcrystalline Cellulose Spheres, Silicified Microcrystalline Cellulose, Cross Carmellose Sodium and Magnesium Stearate. It has a global presence spanning over 75 countries.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024-----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer, Managing Director (Promoter) Ghanshyam A.Patel 45 6/8/2023 4/10/2012
Whole-Time Director (Promoter) Nitin J.Patel 41 6/8/2023 4/10/2012
Whole-Time Director (Promoter) Vasant V.Patel 46 8/28/2023 4/10/2012
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 174 (As of 3/31/2024)
Outstanding Shares: 21,043,000 (As of 9/30/2024)
Stock Exchange: NSE


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 28, 2025